XMU-MP-3
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-136531-5MG | 5 mg | 584,00 | Add | |
HY-136531-1ML | 10mM/1mL | 641,00 | Add | |
HY-136531-10MG | 10 mg | 1'001,00 | Add | |
HY-136531-50MG | 50 mg | 2'927,00 | Add | |
HY-136531-100MG | 100 mg | 4'574,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
XMU-MP-3 is a potent non-covalent BTK inhibitor with IC50s of 10.7 nM and 17.0 nM for BTK WT and BTK C481S mutation in the presence of 10 μM ATP, respectively. XMU-MP-3 also induces apoptosis[1].
Category | Biochemicals |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Cancer, Apoptosis,Protein Tyrosine Kinase/RTK |
Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
Grade | Clinical information: No Development Reported |
Purity | 98.27% |
Molecular Formula | C27H27F3N8O |
Molecular Weight | 536.55 |
CAS-Number | 2031152-08-4 |
Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |